Endovascular treatment of thrombosed fistulae is the standard.pptx

chohl1 0 views 44 slides Oct 08, 2025
Slide 1
Slide 1 of 44
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44

About This Presentation

AV-fistula
Thrombosis
Intervention


Slide Content

Endovascular treatment of thrombosed fistulae is the standard Christian Hohl, EBIR HELIOS Klinikum Siegburg

Endovascular treatment is the standard for thrombosed fistulae and grafts Christian Hohl, EBIR HELIOS Klinikum Siegburg

Pharmacologic Thrombolysis: Lyse and wait Catheter directed thrombolysis ( rtPA , Urokinase ) Mechanical thrombectomy : Aspiration Percutaneous „Fogarty – Maneuver“ Various mechanical devices Thrombectomy techniques

Lyse and wait Puncture of the presumably thrombosed fistula Bolus injection of 4 mg rtPA 20-30 min waiting

Lyse and wait Puncture of the presumably thrombosed fistula Bolus injection of 4 mg rtPA 20-30 min waiting Only recommended in grafts (if at all)

Catheter directed thrombolysis Initial infiltration with 2-5 mg rtPA Continous dosage 2mg/h rtPA for (2-4h) 500 IE Heparin/h

Mechanical Thrombectomy

Only venous application Thrombus maceration and “Fogarty maneuver” Pro Lumen Arrow PTD Castaneda brush AKonya Eliminator Venous and arterial application Manual aspiration Oasis Possis system Clot buster Aspirex (ab medica ) Only arterial application ( venous grafts ) Rotarex (ab medica ) Mechanical devices

Only venous application Thrombus maceration and “Fogarty maneuver” Pro Lumen Arrow PTD Castaneda brush AKonya Eliminator Venous and arterial application Manual aspiration Oasis Possis system Clot buster Aspirex (ab medica ) Only arterial application ( venous grafts ) Rotarex (ab medica ) Mechanical devices

Thrombus maceration Standard PTA balloon Shredding of thrombi Pushing thrombus fragments forward to the lung

Classical aspiration Cheap Quick Difficult in larger diameter vessels

Arrow Trerotola PTD device Motor driven nitinol-basket 5/7 F OTW 0.025“ ( only 7F) HD grafts and fistulae

Arrow Trerotola PTD device

Aspirex (ab medica ) 6, 8 or 10 F OTW 0.018“ Indication : Only fresh thrombi

6 or 8 F OTW 0.018“ Indication : Acute and subacute arterial thrombi Neointimal in- stent restenosis Rotarex (ab medica )

Planning of declotting Clinical examination Compressibility of the vein Venous filling Stenotic string Angiography Access

Transbrachial angiography Simple and low risk with ultrasound guiding Retrograde arterial Puncture (22G) or ArterioFix (20G B.Braun /Germany) Manual contrast injection (1 part contrast – 3 parts saline) Access for diagnostic imaging and monitoring of declotting Diagnostic access

CO 2 - angiography

Native fistulae

Access ? Typical mechanisms

Upper arm fistula – arterial imaging

Retrograde cannulation of shunt vein

Passage of thrombosed segment

Christian Hohl, EBIR

Result

Result

Central thrombosis

Central thrombosis

Literature Data

Patients 54 Procedure 81 Radiocephalic 50 Brachiocephalic 4 Large thrombus 60 Short thrombus 20 Arterial thrombus 1 PTA alone 20 Mechanical thx 58 Lysis 3 Clot buster 23 Hydrolyser 24 Combined 11 Thrombectomy of native fistulae Haage et al. Kidney Int 57

Thrombectomy of native fistulae Technical success

Patients Native fistulas 93 Forearm 56 Upper arm 17 Grafts 162 Data collection 1992-1998 Use of 7 F or 8 F guiding catheter Technical success Forearm 93% Upper arm 76% Grafts 99% Stent rate Forearm 11% Upper arm 41% Grafts 45% 45% Aspiration thrombectomy Turmel -Rodrigues et al Kidney Int 57 (2000) 1124

Forearm AVF ( thrombosed ) Patency @ 6 months 74 %, @ 12 months 47 % Upper – arm AVF ( thrombosed ) Patency @ 6 months 27 %, @ 12 months 27 % Prosthetic grafts ( thrombosed ) Patency @ 6 months 32 %, @ 12 months 17 % Percutaneous intervention : Patency in BC fistulae Turmel -Rodrigues NDT (2000) 2029

Percutaneous intervention : Patency in BC fistulae Turmel -Rodrigues NDT (2000) 2029

Henk F. M. Smits et al Nephrol Dial Transplant (2002) 17: 467-473 Percutaneous thrombolysis of thrombosed haemodialysis access grafts : comparison of three mechanical devices

Arterial embolization Venous embolization Pulmonary embolism Rupture / hematoma Complications

Petronis et al Am J Kidney Dis 34 (1999) 207 Thrombolysis 12/ 13 patients no evidence of PE ( nuclear scan ) Smits et al Am Soc Nephrol 8 (1997) 1458 Mechanical and pharmacomechanical clot dissolution 8/23 patients (35%) evidence of PE ( nuclear scan ) Clinical symptoms of PE in one (5%) Swan et al J Vasc Interv Radiol 6 (1995) 683 Intentional pulmonary clot dislodgement 12/22 patients (59%) evidence of PE ( nuclear scan ) 2 deaths related to PE 10/12 asymptomatic Risk of PE

Conclusion 1 High technical success rate for endovascular treatment Various „ devices “ available . Personal experience and cost !

Conclusion 2 Surgical approach – first choice in forearm fistulae Percutaneous approach – first choice for the rest , but Beware of : Big aneurysms Old thrombus Infected fistula

Conclusion 3 Strategy depends very much on the local situation Avail ability of well trained interventionalist / surgeon

Graft Thrombose

evc 2013 Christian Hohl, EBIR 8 F 6 F Double puncture Loop Graft

evc 2013 Christian Hohl, EBIR 8 F Apex Punktion Loop Graft

evc 2013 Christian Hohl, EBIR Apex Punktion
Tags